Shanghai Kaibao Pharmaceutical CO.,Ltd (SHE:300039)
China
· Delayed Price · Currency is CNY 5.88
-0.02 (-0.34%)
Apr 30, 2025, 3:04 PM CST
SHE:300039 Revenue
In the year 2024, Shanghai Kaibao Pharmaceutical CO.,Ltd had annual revenue of 1.47B CNY, down -7.57%. Shanghai Kaibao Pharmaceutical CO.,Ltd had revenue of 400.64M in the quarter ending March 31, 2025, a decrease of -15.74%.
Revenue
1.47B
Revenue Growth
-7.57%
P/S Ratio
4.17
Revenue / Employee
1.11M
Employees
1,325
Market Cap
6.15B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.47B | -120.73M | -7.57% |
| Dec 31, 2023 | 1.59B | 475.20M | 42.47% |
| Jan 1, 2023 | 1.12B | 18.27M | 1.66% |
| Jan 1, 2022 | 1.10B | 192.57M | 21.21% |
| Dec 31, 2020 | 908.01M | -511.02M | -36.01% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Medicine | 29.19B |
| Shenzhen Mindray Bio-Medical Electronics | 35.59B |
| WuXi AppTec | 39.59B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
| Aier Eye Hospital Group | 21.81B |
| Sichuan Biokin Pharmaceutical | 5.82B |
| Shanghai United Imaging Healthcare | 10.43B |
| Yunnan Baiyao Group Co.,Ltd | 40.10B |